Thiogenesis Therapeutics Market Cap

Thiogenesis Therapeutics has a market cap or net worth of CAD 30.49 million as of May 2, 2025. Its market cap has increased by 4.61% in one year.

Market Cap

30.49M

Enterprise Value

26.34M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.66

Market Cap Chart

Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 30.49M, an increase of 118.50%. That is a compound annual growth rate of 29.16%.

Market Cap History

Date	Market Cap	% Change
May 2, 2025	30.49M	11.67%
Dec 31, 2024	27.31M	-18.31%
Dec 29, 2023	33.43M	48.30%
Dec 30, 2022	22.54M	61.52%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Green Thumb Industries	2.09B
dentalcorp Holdings	1.66B
Sienna Senior Living	1.56B
Trulieve Cannabis	1.30B
Extendicare	1.17B
Curaleaf Holdings	1.01B
WELL Health Technologies	1.00B
Cronos Group	990.75M

Market Cap Rankings